ID   GPR17_RAT               Reviewed;         339 AA.
AC   Q09QM4;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 1.
DT   02-OCT-2024, entry version 119.
DE   RecName: Full=Uracil nucleotide/cysteinyl leukotriene receptor;
DE            Short=UDP/CysLT receptor;
DE   AltName: Full=G-protein coupled receptor 17;
GN   Name=Gpr17 {ECO:0000312|RGD:1589785};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:ABG75921.1}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley {ECO:0000312|EMBL:ABG75921.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:ABG75921.1};
RX   PubMed=16990797; DOI=10.1038/sj.emboj.7601341;
RA   Ciana P., Fumagalli M., Trincavelli M.L., Verderio C., Rosa P., Lecca D.,
RA   Ferrario S., Parravicini C., Capra V., Gelosa P., Guerrini U.,
RA   Belcredito S., Cimino M., Sironi L., Tremoli E., Rovati G.E., Martini C.,
RA   Abbracchio M.P.;
RT   "The orphan receptor GPR17 identified as a new dual uracil
RT   nucleotides/cysteinyl-leukotrienes receptor.";
RL   EMBO J. 25:4615-4627(2006).
CC   -!- FUNCTION: Dual specificity receptor for uracil nucleotides and
CC       cysteinyl leukotrienes (CysLTs). Signals through G(i) and inhibition of
CC       adenylyl cyclase. May mediate brain damage by nucleotides and CysLTs
CC       following ischemia. {ECO:0000269|PubMed:16990797}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain, kidney, and heart. Highest
CC       level in brain. {ECO:0000269|PubMed:16990797}.
CC   -!- INDUCTION: In brain areas affected by ischemia.
CC       {ECO:0000269|PubMed:16990797}.
CC   -!- MISCELLANEOUS: Administration of an antisense oligonucleotide specific
CC       for GPR17 significantly reduced brain damage following ischemia.
CC       {ECO:0000269|PubMed:16990797}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ777767; ABG75921.1; -; mRNA.
DR   RefSeq; NP_001065245.1; NM_001071777.1.
DR   RefSeq; XP_006254666.1; XM_006254604.3.
DR   AlphaFoldDB; Q09QM4; -.
DR   SMR; Q09QM4; -.
DR   STRING; 10116.ENSRNOP00000032046; -.
DR   BindingDB; Q09QM4; -.
DR   ChEMBL; CHEMBL4295807; -.
DR   GlyCosmos; Q09QM4; 2 sites, No reported glycans.
DR   GlyGen; Q09QM4; 2 sites.
DR   PhosphoSitePlus; Q09QM4; -.
DR   PaxDb; 10116-ENSRNOP00000032046; -.
DR   Ensembl; ENSRNOT00000104846.1; ENSRNOP00000091710.1; ENSRNOG00000065480.1.
DR   Ensembl; ENSRNOT00060047974; ENSRNOP00060039918; ENSRNOG00060027654.
DR   Ensembl; ENSRNOT00065019996; ENSRNOP00065015342; ENSRNOG00065012288.
DR   GeneID; 767613; -.
DR   KEGG; rno:767613; -.
DR   UCSC; RGD:1589785; rat.
DR   AGR; RGD:1589785; -.
DR   CTD; 2840; -.
DR   RGD; 1589785; Gpr17.
DR   eggNOG; ENOG502QW6S; Eukaryota.
DR   GeneTree; ENSGT01120000271830; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; Q09QM4; -.
DR   OMA; TCLNGAM; -.
DR   OrthoDB; 5383533at2759; -.
DR   PhylomeDB; Q09QM4; -.
DR   TreeFam; TF330775; -.
DR   Reactome; R-RNO-391906; Leukotriene receptors.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-417957; P2Y receptors.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   PRO; PR:Q09QM4; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000025745; Expressed in frontal cortex and 13 other cell types or tissues.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central.
DR   GO; GO:0033612; F:receptor serine/threonine kinase binding; IPI:RGD.
DR   GO; GO:0002862; P:negative regulation of inflammatory response to antigenic stimulus; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEP:RGD.
DR   GO; GO:0007200; P:phospholipase C-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0035025; P:positive regulation of Rho protein signal transduction; IBA:GO_Central.
DR   CDD; cd15161; 7tmA_GPR17; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   PANTHER; PTHR24232; G-PROTEIN COUPLED RECEPTOR; 1.
DR   PANTHER; PTHR24232:SF44; URACIL NUCLEOTIDE_CYSTEINYL LEUKOTRIENE RECEPTOR; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01157; P2YPURNOCPTR.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Receptor; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..339
FT                   /note="Uracil nucleotide/cysteinyl leukotriene receptor"
FT                   /id="PRO_0000278172"
FT   TOPO_DOM        1..36
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        37..57
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        58..64
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        65..85
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        86..105
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        106..126
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        127..147
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        148..168
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        169..195
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        196..216
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        217..232
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        233..253
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        254..280
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        281..301
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        302..339
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        14
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        176
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        104..181
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
SQ   SEQUENCE   339 AA;  37870 MW;  19239CC3EE0C11D7 CRC64;
     MDGLETALPS LTDNASLAYS EQCGQETPLE NMLFACFYLL DFILAFVGNA LALWLFIWDH
     KSGTPANVFL MHLAVADLSC VLVLPTRLVY HFSGNHWPFG EIPCRLTGFL FYLNMYASIY
     FLTCISADRF LAIVHPVKSL KLRRPLYAHL ACAFLWIVVA VAMAPLLVSP QTVQTNHTVV
     CLQLYREKAS HHALASLAVA FTFPFITTVT CYLLIIRSLR QGPRIEKHLK NKAVRMIAMV
     LAIFLICFVP YHIHRSVYVL HYRGGGTSCS AQRALALGNR ITSCLTSLNG ALDPVMYFFV
     AEKFRHALCN LLCSKRLTGP PPSFEGKTNE SSLSARSEL
//
